These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24867973)

  • 1. SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors.
    Huber AD; Michailidis E; Schultz ML; Ong YT; Bloch N; Puray-Chavez MN; Leslie MD; Ji J; Lucas AD; Kirby KA; Landau NR; Sarafianos SG
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4915-9. PubMed ID: 24867973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors.
    Ballana E; Badia R; Terradas G; Torres-Torronteras J; Ruiz A; Pauls E; Riveira-Muñoz E; Clotet B; Martí R; Esté JA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4804-13. PubMed ID: 24913159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV host factor SAMHD1 regulates viral sensitivity to nucleoside reverse transcriptase inhibitors via modulation of cellular deoxyribonucleoside triphosphate (dNTP) levels.
    Amie SM; Daly MB; Noble E; Schinazi RF; Bambara RA; Kim B
    J Biol Chem; 2013 Jul; 288(28):20683-91. PubMed ID: 23744077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.
    Sluis-Cremer N; Sheen CW; Zelina S; Torres PS; Parikh UM; Mellors JW
    Antimicrob Agents Chemother; 2007 Jan; 51(1):48-53. PubMed ID: 17088490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
    Geleziunas R; Gallagher K; Zhang H; Bacheler L; Garber S; Wu JT; Shi G; Otto MJ; Schinazi RF; Erickson-Viitanen S
    Antivir Chem Chemother; 2003 Jan; 14(1):49-59. PubMed ID: 12790516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase.
    Bradshaw D; Malik S; Booth C; Van Houtte M; Pattery T; Waters A; Ainsworth J; Geretti AM
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4489-91. PubMed ID: 17876005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
    Caron M; Auclair M; Lagathu C; Lombès A; Walker UA; Kornprobst M; Capeau J
    AIDS; 2004 Nov; 18(16):2127-36. PubMed ID: 15577645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
    AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors.
    Xu HT; Colby-Germinario SP; Oliveira M; Rajotte D; Bethell R; Wainberg MA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4515-26. PubMed ID: 24867966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host SAMHD1 protein promotes HIV-1 recombination in macrophages.
    Nguyen LA; Kim DH; Daly MB; Allan KC; Kim B
    J Biol Chem; 2014 Jan; 289(5):2489-96. PubMed ID: 24352659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.
    Hill SA; Lloyd PA; McDonald S; Wykoff J; Derse D
    J Infect Dis; 2003 Aug; 188(3):424-7. PubMed ID: 12870124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.
    White KL; Chen JM; Margot NA; Wrin T; Petropoulos CJ; Naeger LK; Swaminathan S; Miller MD
    Antimicrob Agents Chemother; 2004 Mar; 48(3):992-1003. PubMed ID: 14982794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir.
    Barnas D; Koontz D; Bazmi H; Bixby C; Jemsek J; Mellors JW
    Antivir Ther; 2010; 15(3):437-41. PubMed ID: 20516563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.
    Parikh UM; Bacheler L; Koontz D; Mellors JW
    J Virol; 2006 May; 80(10):4971-7. PubMed ID: 16641288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.
    Shi M; Wang X; De Clercq E; Takao S; Baba M
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2600-4. PubMed ID: 17470654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.
    Lahouassa H; Daddacha W; Hofmann H; Ayinde D; Logue EC; Dragin L; Bloch N; Maudet C; Bertrand M; Gramberg T; Pancino G; Priet S; Canard B; Laguette N; Benkirane M; Transy C; Landau NR; Kim B; Margottin-Goguet F
    Nat Immunol; 2012 Feb; 13(3):223-228. PubMed ID: 22327569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vpx requires active cellular dNTP biosynthesis to effectively counteract the anti-lentivirus activity of SAMHD1 in macrophages.
    Bowen NE; Tao S; Cho YJ; Schinazi RF; Kim B
    J Biol Chem; 2023 Aug; 299(8):104984. PubMed ID: 37390988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAMHD1-dependent retroviral control and escape in mice.
    Rehwinkel J; Maelfait J; Bridgeman A; Rigby R; Hayward B; Liberatore RA; Bieniasz PD; Towers GJ; Moita LF; Crow YJ; Bonthron DT; Reis e Sousa C
    EMBO J; 2013 Sep; 32(18):2454-62. PubMed ID: 23872947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAMHD1 restricts HIV-1 replication and regulates interferon production in mouse myeloid cells.
    Zhang R; Bloch N; Nguyen LA; Kim B; Landau NR
    PLoS One; 2014; 9(2):e89558. PubMed ID: 24586870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptase.
    Grant PM; Taylor J; Nevins AB; Calvez V; Marcelin AG; Wirden M; Zolopa AR
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1520-5. PubMed ID: 20124005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.